Protective effects of cystone, a polyherbal ayurvedic preparation, on cisplatin-induced renal toxicity in rats

Journal of Ethnopharmacology

Volumn 62, Issue 1, 1998, Pages 1-6

  Rao, Mahadev ^a   Rao, M N A ^a  

^a MANIPAL COLLEGE OF PHARMACEUTICAL SCIENCES   (India)

Author keywords

Cisplatin; Cystone; Lipid peroxidation; Renal toxicity; Serum creatinine; Urea nitrogen

Indexed keywords

AYURVEDIC DRUG; CISPLATIN; CREATININE; CYSTONE; NITROGEN; PROTEIN; UNCLASSIFIED DRUG; UREA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONCENTRATION RESPONSE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; CREATININE URINE LEVEL; INTRAPERITONEAL DRUG ADMINISTRATION; KIDNEY CORTEX SLICE; KIDNEY FUNCTION; LEUKOCYTE COUNT; LIPID PEROXIDATION; MALE; NEPHROTOXICITY; NONHUMAN; PROTEIN URINE LEVEL; RAT; UREA NITROGEN BLOOD LEVEL; WEIGHT REDUCTION;

ANIMALS; ANTINEOPLASTIC AGENTS; BLOOD UREA NITROGEN; BODY WEIGHT; CISPLATIN; CREATININE; DRUG ANTAGONISM; KIDNEY; KIDNEY FUNCTION TESTS; LIPID PEROXIDATION; MALE; MEDICINE, AYURVEDIC; PLANT EXTRACTS; PLANTS, MEDICINAL; RATS; RATS, WISTAR;

EID: 0032146654     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-8741(98)00003-8     Document Type: Article

References (16)

1. Baldew G.S., van den Hamer C.J.A., Los G., Vermuelen N.P.E., de Goeij J.J.M., Mc Vie J.G. Selenium induced protection against cis-diaminodichloroplatinum nephrotoxicity in mice and rats. Cancer Research. 49:1989;3020-3023.
2. Bull J.M.C., Strebel F.R., Sunderland B.A., Bulger R.E., Edwards M., Siddik Z.H., Newman R.A. 0-(β-hydroxyethyl)-rutoside mediated protection of renal injury associated with cis-diaminodichloroplatinum/hyperthermia treatment. Cancer Research. 48:1988;2239-2244.
3. Garg S.K., Singh R.C. Role of cystone in burning micturution. Probe. 2:1985;119-121.
4. Godkar P.B. Textbook of Medical Laboratory Technology. 1994;Bhalani Publishing House, Bombay.
5. Goldstein R.S., Mayor G.H. The nephrotoxicity of cisplatin. Life Sciences. 32:1983;685-690.
6. Inselmann G., Blohmer A., Kottny W., Nellessen U., Heidemann H.T. Modification of cisplatin-induced renal p-aminohippurate uptake alteration and lipid peroxidation by thiols, Ginkgo biloba extract, desferroxamine and torbafylline. Nephron. 70:1995;425-429.
7. Lowry O.H., Rosenbrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin-Phenol reagent. Journal of Biological Chemistry. 193:1951;265-275.
8. Madias N.E., Harrington J.T. Platinum nephrotoxicity. American Journal of Medicine. 65:1978;307-314.
9. Misgar M.S. Controlled trial in 100 cases with nephro-urethrolithiasis with cystone, an indigenous drug and other advanced methods. Current Medical Practices. 5:1982;26-29.
10. Nadkarni A.K. Dr K.M. Nadkarni's Indian Materia Medica. I-II:1992;Popular Prakashan, Bombay.
11. Rai S.C. Clinical trials with cystone in urolithiasis. Current Medical Practices. 9:1960;484-487.
12. Rajakumar D.V., Rao M.N.A. Dehydrozingerone and isoeugenol as inhibitors of lipid peroxidation and as free radical scavengers. Biochemical Pharmacology. 46:1993;2067-2072.
13. Rozeneweig M., van Hoff D.D., Slavil M., Muggia F.M. cis-Diamine dichloroplatinum, a new anticancer agent. Annals of Internal Medicine. 86:1977;803-809.
14. Sengupta S. Cystone in urinary tract complaints during pregnancy. Medicine and Surgery. 27:1987;7-11.
15. Sharma B.M., Panagariya A., Jain K. Clinical trial of cystone in various renal disorders. Probe. 2:1983;113-114.
16. Yamasaki F., Ishibashi M., Nakakuki M., Watanabe M., Shiukawa T., Mizota M. Protective action of ulinastatin against cisplatin nephrotoxicity in mice and its effect on the lysosomal fragility. Nephron. 74:1996;158-167.